PUBLICATIONS · 30559051
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2019 Jan
- First author
- Jackson GH
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2019 Jan;20(1):5-6. doi: 10.1016/S1470-2045(18)30764-2.
- note
- Source null
- related pmid
- 30559052
- relationship
- Comment in
Authors and identifiers
- name
- Jackson GH
- type
- Author
- name
- Davies FE
- type
- Author
- name
- Pawlyn C
- type
- Author
- name
- Cairns DA
- type
- Author
- name
- Striha A
- type
- Author
- name
- Collett C
- type
- Author
- name
- Hockaday A
- type
- Author
- name
- Jones JR
- type
- Author
- name
- Kishore B
- type
- Author
- name
- Garg M
- type
- Author
- name
- Williams CD
- type
- Author
- name
- Karunanithi K
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Jackson GH
- type
- Author
- name
- Davies FE
- type
- Author
- name
- Pawlyn C
- type
- Author
- name
- Cairns DA
- type
- Author
- name
- Striha A
- type
- Author
- name
- Collett C
- type
- Author
- name
- Hockaday A
- type
- Author
- name
- Jones JR
- type
- Author
- name
- Kishore B
- type
- Author
- name
- Garg M
- type
- Author
- name
- Williams CD
- type
- Author
- name
- Karunanithi K
- type
- Author
- bibliography ids
- nci-bib-8e158551329dd5b377c14ba7
- book metadata
- content sha256
- ab387f40c55b0e615ae92b6ab88bdab9004591c6f529b469c3fd53e672278ffb
- document type
- citation
- dois
- 10.1016/S1470-2045(18)30687-9
- electronic publication date
- display
- 2018 Dec 14
- precision
- day
- year
- 2018
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:30559051
- immutable id
- pubmed:30559051@ab387f40c55b0e615ae92b6ab88bdab9004591c6f529b469c3fd53e672278ffb
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 1
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 57-73
- volume
- 20
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2019 Jan;20(1):5-6. doi: 10.1016/S1470-2045(18)30764-2.
- note
- Source null
- related pmid
- 30559052
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 30559051
- provenance
- batch id
- 438b2803888025c6cf56
- provider
- NCBI PubMed ESummary
- record sha256
- 96ffce47129372873e00209849a2f7cad70e08be3a0f25b620b251465ca4706e
- response sha256
- 0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
- retrieved at
- 2026-09-09T23:47:36.359220+00:00
- publication date
- display
- 2019 Jan
- precision
- month
- year
- 2019
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.
Preserved source evidence · Not medical advice
Triangle